XML 67 R45.htm IDEA: XBRL DOCUMENT v3.26.1
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Fair Value, by Balance Sheet Grouping The following tables summarize the Company’s assets and liabilities measured at fair value on a recurring basis. Financial
assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value
measurement. There were no assets and liabilities measured at fair value on a nonrecurring basis.
Successor
December 31, 2025
(in thousands)
Balance Sheet Location
Level 1
Level 2
Level 3
Assets:
Cash and cash equivalents
Cash and cash equivalents
$798,423
$
$
Restricted cash
Restricted cash
108,263
Investment in GLPI partnership
Other assets
18,946
Investment in The Star
Other assets
301,285
Derivative assets not designated as hedging instruments:
Cross currency swaps
Prepaid expenses and other current assets
3,975
Cross currency swaps
Other assets
1,111
Total derivative assets at fair value
5,086
Total assets
$1,207,971
$24,032
$
Liabilities:
Contingent consideration
Accrued and other current liabilities
$
$
$115,000
Contingent consideration
Other long-term liabilities
8,885
Derivative liabilities not designated as hedging instruments:
Cross currency swaps
Accrued and other current liabilities
17,643
Cross currency swaps
Other long-term liabilities
51,716
Derivative liabilities designated as hedging instruments:
Interest rate contracts
Accrued and other current liabilities
9,166
Interest rate contracts
Other long-term liabilities
29,854
Total derivative liabilities at fair value
108,379
Total liabilities
$
$108,379
$123,885
Predecessor
December 31, 2024
(in thousands)
Balance Sheet Location
Level 1
Level 2
Level 3
Assets:
Cash and cash equivalents
Cash and cash equivalents
$171,233
$
$
Restricted cash
Restricted cash
60,021
Investment in GLPI partnership
Other assets
20,418
Derivative assets not designated as hedging instruments
Cross currency swaps
Prepaid expenses and other current assets
4,871
Cross currency swaps
Other assets
615
Derivative assets designated as hedging instruments:
Interest rate contracts
Prepaid expenses and other current assets
340
Interest rate contracts
Other assets
336
Cross currency swaps
Prepaid expenses and other current assets
148
Cross currency swaps
Other assets
13,181
Total derivative assets at fair value
19,491
Total assets
$231,254
$39,909
$
Liabilities:
Contingent consideration
Other long-term liabilities
$
$
$59,923
Derivatives not designated as hedging instruments:
Sinclair Performance Warrants
Other long-term liabilities
58,668
Cross currency swaps
Other long-term liabilities
11,174
Derivative liabilities designated as hedging instruments:
Interest rate contracts
Accrued and other current liabilities
1,855
Interest rate contracts
Other long-term liabilities
13,372
Cross currency swaps
Accrued and other current liabilities
1,189
Cross currency swaps
Other long-term liabilities
1,624
Total derivative liabilities at fair value
29,214
58,668
Total liabilities
$
$29,214
$118,591
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation The following table summarizes the changes in fair value of the Company’s Level 3 assets and liabilities:
(in thousands)
Sinclair
Performance
Warrant
Liability
Contingent
Consideration
Liability
Balance as of December 31, 2023 (Predecessor)
$44,703
$58,580
Change in fair value
13,965
1,343
Balance as of December 31, 2024 (Predecessor)
58,668
59,923
Change in fair value
1,180
786
Balance as of February 7, 2025 (Predecessor)
$59,848
$60,709
Balance as of February 8, 2025 (Successor)
$
$60,709
Change in fair value
63,176
Balance as of December 31, 2025 (Successor)
$
$123,885
Derivative Instruments, Gain (Loss) The gains (losses) recognized in the consolidated statements of operations for derivative instruments are as follows:
Successor
Predecessor
Consolidated Statements of
Operations Location
Period from
February 8,
2025 to
December 31,
2025
Period from
January 1,
2025 to
February 7,
2025
Year Ended
December 31,
2024
(in thousands)
Derivatives not designated as hedging instruments
Deal Contingent FX Forwards
Other non-operating income
(expense), net
$(774)
$
$
Sinclair Performance Warrants
Other non-operating income
(expense), net
(1,180)
(13,965)
Cross currency swaps(1)
Other non-operating income
(expense), net
11,696
50
(9,078)
Derivatives designated as hedging instruments
Interest rate contracts
Interest expense, net
$4,422
$(105)
$(11,031)
Cross currency swaps
Interest expense, net
2,063
7
(3,658)
__________________________________
(1)Amounts during the year ended December 31, 2024 (Predecessor), as a result of the Company’s de-designation of its EUR-GBP cross currency swaps as
net investment hedges, are included in General and administrative.
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments In the table below, the carrying amounts of
the Company’s long-term debt is net of debt issuance costs, debt discounts and fair value adjustments. Refer to Note 14Long-
Term Debt” for further information.
Successor
Predecessor
 
December 31, 2025
December 31, 2024
(in thousands)
Carrying
Amount
Fair Value
Carrying
Amount
Fair Value
Term Loan Facility
$1,408,953
$1,458,438
$1,858,800
$1,792,804
Intralot British Term Loan
537,234
519,315
Intralot Greek Term Loan
234,962
230,370
Intralot 6.00% Retail Bond due 2029
157,214
155,022
5.625% Senior Notes due 2029
580,494
562,500
738,517
587,813
5.875% Senior Notes due 2031
517,458
484,181
721,456
535,631
Intralot 6.75% Senior Secured Notes due 2031
708,787
699,706
Intralot Supplemental Indenture
2,436
2,436
Intralot Floating Rate Senior Notes due 2031
353,119
347,858